Democrats May Be Wary of Pushing Forward Trump’s Revamped International Reference Pricing Rule

 
• By Sarah Karlin-Smith
Medicine cabinet
Medicare beneficiaries might lose access to drugs under a newly finalized Trump drug pricing rule • Source: Shutterstock

More from Pricing Debate

More from Market Access